XML 48 R41.htm IDEA: XBRL DOCUMENT v3.25.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Share-based Payment Arrangement, Activity

The following table presents the Company's total stock-based compensation expense:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Employee stock-based compensation expense

 

 

 

 

 

 

 

 

 

 

 

Pre-tax

$

926

 

 

$

556

 

 

$

2,872

 

 

$

1,593

 

Post-tax (1)

 

732

 

 

 

439

 

 

 

2,269

 

 

 

1,258

 

Director stock-based compensation expense

 

 

 

 

 

 

 

 

 

 

 

Pre-tax

 

121

 

 

 

138

 

 

 

379

 

 

 

310

 

Post-tax (1)

 

96

 

 

 

109

 

 

 

300

 

 

 

245

 

(1) The after-tax amounts are determined using the 21% corporate federal tax rate.

Schedule of Nonvested Share Activity

The following table presents certain information related to the activity of the Company's non-vested restricted common stock grants:

 

 

Number of
Restricted
Shares

 

 

Weighted
Average Grant
Date Fair Value

 

Outstanding as of December 31, 2024

 

606,411

 

 

$

6.23

 

Granted

 

466,672

 

 

 

11.48

 

Less: Forfeited

 

1,009

 

 

 

11.59

 

Less: Vested

 

494,793

 

 

 

5.29

 

Outstanding as of September 30, 2025

 

577,281

 

 

$

10.12

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The following weighted-average assumptions were used to value the stock options granted:

 

 

2025

 

 

2024

 

Expected annual dividend yield

 

%

 

 

%

Expected volatility

 

88.51

%

 

 

86.92

%

Risk-free interest rate

 

3.87

%

 

 

4.37

%

Expected term

6 years

 

 

6 years

 

Schedule of Share-based Compensation, Stock Options and Stock Appreciation Rights Award Activity

The following table presents certain information related to the activity of the Company's stock option grants:

 

 

 

Number of
Stock Options

 

 

Weighted
Average
Exercise Prices

 

 

Weighted Average Remaining Contractual Term (years)

 

 

Aggregate
Intrinsic
Value
(2)

 

Outstanding as of December 31, 2024

 

1,130,035

 

 

$

4.12

 

 

 

7.21

 

 

$

10,202,000

 

Granted

 

76,141

 

 

 

11.63

 

 

 

 

 

 

 

Less: Forfeited

 

 

 

 

 

 

 

 

 

 

 

Less: Expired

 

 

 

 

 

 

 

 

 

 

 

Less: Exercised

 

240,446

 

 

 

3.17

 

 

 

 

 

 

 

Outstanding as of September 30, 2025

 

965,730

 

 

$

4.95

 

 

 

6.76

 

 

$

6,514,000

 

 

 

 

 

 

 

 

 

 

 

 

Vested as of September 30, 2025 ⁽¹⁾

 

1,475,570

 

 

$

4.24

 

 

 

6.28

 

 

$

5,996,000

 

Exercisable as of September 30, 2025

 

799,869

 

 

$

4.24

 

 

 

6.28

 

 

$

5,996,000

 

(1) The vested shares are calculated based on all vested shares at September 30, 2025, inclusive of those that have since expired. The weighted average exercise prices, weighted-average remaining contractual term and aggregate intrinsic value is calculated based on only vested shares that are outstanding and exercisable at September 30, 2025.

(2) Presented in ones.